Сделай Сам Свою Работу на 5

Bao WL, Williams AJ, Faden AI, Tortella FC.

Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia.

Brain Res 2001;922(2):173-179

 

Bates B, Hirt L, Thomas S, Akbarian S, Le D, Amin-Hanjani S, Whalen M, et al.Neurotrophin-3 promotes cell death induced in cerebral ischemia, oxygen-glucose deprivation, and oxidative stress: possible involvement of oxygen free radicals.

Neurobiol Dis 2002;9(1):24-37

 

Beech JS, Reckless J, Mosedale DE, Grainger DJ, Williams SC, Menon DK.

Neuroprotection in ischemia-reperfusion injury: an antiinflammatory approach using a novel broad- spectrum chemokine inhibitor.

J Cereb Blood Flow Metab 2001;21(6):683-689

 

Bensadoun JC, de Almeida LP, Dreano M, Aebischer P, Deglon N.

Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome.

Eur J Neurosci 2001;14(11):1753-1761

 

Berger JR, Arendt G.

HIV dementia: the role of the basal ganglia and dopaminergic systems. J Psychopharmacol 2000;14(3):214-221

 

Bergeron M, Yu AY, Solway KE, Semenza GL, Sharp FR.

Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain.

Eur J Neurosci 1999;11(12):4159-4170

 

Bernardi F, Lanzone A, Cento RM, Spada RS, Pezzani I, Genazzani AD, Luisi S, Luisi M, Petraglia F, Genazzani AR.

Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia.

Eur J Endocrinol 2000;142(5):466-471

 

Bhojak TJ, DeKosky ST, Ganguli M, Kamboh MI.

Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease.

Neurosci Lett 2000;288(1):21-4

 

Bidmon HJ, Emde B, Kowalski T, Schmitt M, Mayer B, Kato K, Asayama K, et al.

Nitric oxide synthase-I containing cortical interneurons co-express antioxidative enzymes and anti- apoptotic Bcl-2 following focal ischemia: evidence for direct and indirect mechanisms towards their resistance to neuropathology.

J Chem Neuroanat 2001;22(3):167-184

 

Blondeau N, Widmann C, Lazdunski M, Heurteaux C.

Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci 2001;21(13):4668-4677

 

Bogaert L, Scheller D, Moonen J, Sarre S, Smolders I, Ebinger G, Michotte Y.

Neurochemical changes and laser Doppler flowmetry in the endothelin-1 rat model for focal cerebral ischemia.

Brain Res 2000;887(2):266-275


Borlongan CV, Yamamoto M, Takei N, Kumazaki M, Ungsuparkorn C, et al.

Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia. FASEB J 2000;14(10):1307-1317

 

Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ.

Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci 2001;21 (15):5528-5534

 

Calapai G, Marciano MC, Corica F, Allegra A, Parisi A, Frisina N, Caputi AP, et al.Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol 2000;401(3):349-356

 

Callaway JK.

Investigation of AM-36:a novel neuroprotective agent. Clin Exp Phar Phys 2001;28(11):913-18

 

Capsoni S, Ugolini G, Comparini A, Ruberti F, Berardi N, Cattaneo A.Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. PNAS USA 2000;97(12):6826-6831

 

Carroll JE, Hess DC, Howard EF, Hill WD.



Is nuclear factor-kappaB a good treatment target in brain ischemia/reperfusion injury? Neuroreport 2000;11(9):R1-R4

 

Casolini P, Catalani A, Zuena AR, Angelucci L.

Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat.

J Neurosci Res 2002;68(3):337-343

 

Castillo J, Davalos A, Alvarez-Sabin J, Pumar JM, Leira R, Silva Y, et al.

Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 2002;58(4):624-629

 

Castillo J, Rama R, Davalos A.

Nitric oxide-related brain damage in acute ischemic stroke. Stroke 2000;31(4): 852-857

 

Centonze D, Saulle E, Pisani A, Bernardi G, Calabresi P.

Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia. Brain 2001;124(Pt 9):1855-1865

 

Charles V, Mezey E, Reddy PH, Dehejia A, Young TA, Polymeropoulos MH, et al.

Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models.

Neurosci Lett 2000;289(1):29-32

 

Chavez JC, Agani F, Pichiule P, LaManna JC.

Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia. J Appl Physiol 2000;89(5):1937-1942

 

Chen CJ, Cheng FC, Liao SL, Chen WY, Lin NN, Kuo JS.

Effects of naloxone on lactate, pyruvate metabolism and antioxidant enzyme activity in rat cerebral ischemia/reperfusion. Neurosci Lett 2000;287(2):113-116

 

Chen J, Xu W, Jiang H.

17 beta-estradiol protects neurons from ischemic damage and attenuates accumulation of extracellular excitatory amino acids.

Anesth Analg 2001;92(6):1520-1523


Chen SH, Cheung RT.

Peripheral and central administration of neuropeptide Y in a rat middle cerebral artery occlusion stroke model reduces cerebral blood flow and increases infarct volume.

Brain Res 2002;927(2):138-143

 

Chiappe-Gutierrez M, Kitzmueller E, Labudova O, Fuerst G, Hoeger H, et al.

mRNA levels of the hypoxia inducible factor (HIF-1) and DNA repair genes in perinatal asphyxia of the rat.

Life Sci 1998;63(13):1157-1167

 

Cho S, Park EM, Kim Y, Liu N, Gal J, Volpe BT, Joh TH.

Early c-Fos induction after cerebral ischemia: a possible neuroprotective role. J Cereb Blood Flow Metab 2001;21(5):550-556

 

Cholerton B, Gleason CE, Baker LD, Asthana S.Estrogen and Alzheimer's disease: the story so far. Drugs Aging 2002;19(6):405-27

 

Cipolla MJ, Lessov N, Clark WM, Haley EC Jr.

Postischemic attenuation of cerebral artery reactivity is increased in the presence of tissue plasminogen activator.

Stroke 2000;31(4):940-945

 

Clark WM, Lutsep HL.

Potential of anticytokine therapies in central nervous system ischaemia. Expert Opin Biol Ther 2001;1(2):227-237

 

Clemens JA.

Cerebral ischemia: gene activation, neuronal injury, and the protective role of antioxidants. Free Radic Biol Med 2000;28(10):1526-1531

 

Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, et al.

Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.

Neuroscience 2000;98(1):79-87

 

Croll SD, Wiegand SJ.

Vascular growth factors in cerebral ischemia. Mol Neurobiol 2001;23(2):121-135

 

Croom J, Taylor IL.

Neuropeptide Y, peptide YY and aluminum in Alzheimer's disease: is there an etiological relationship? J Inorg Biochem 2001;87(1-2):51-56

 

Cuzzocrea S, Costantino G, Gitto E, Mazzon E, Fulia F, Serraino I, et al.

Protective effects of melatonin in ischemic brain injury. J Pinl Res 2000;29(4):217-27

 

Cuzzocrea S, Mazzon E, Costantino G, et al.

Beneficial effects of n-acetylcysteine on ischaemic brain injury. Br J Pharmacol 2000;130(6):1219-1226

 

Czub S, Koutsilieri E, Sopper S, Czub M, Stahl-Hennig C, Muller JG, et al.

Enhancement of central nervous system pathology in et al.rly simian immunodefici-ency virus infection by dopaminergic drugs.

Acta Neuropathol 2001;101(2): 85-91

 

Danbolt NC.

Glutamate uptake.

Prog Neurobiol 2001;65(1):1-105


Dani JA.

Overview of nicotinic receptors and their roles in the central nervous system. Biol Psychiatry 2001;49(3):166-174

 

Danilova RA, Rud'ko OI, Korotkova TM, Obukhova MF, Ashmarin IP.

The effects of immunization against cholecystokinin fragment 30-33 in the behavior of white rats. Neurosci Behav Physiol 2002;32(2):189-194

 

De Cristobal J, Moro MA, Davalos A, Castillo J, Leza JC, Camarero J, et al.

Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats.

J Neurochem 2001;79(2):456-459

 

DeKosky ST.

Epidemiology and pathophysiology of Alzheimer's disease. Clin Cornerstone 2001;3(4):15-26

 

Diez M, Koistinaho J, Kahn K, Games D, Hokfelt T.

Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein-initial observations.

Neuroscience 2000;100(2):259-286

 

Digicaylioglu M, Lipton SA.

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades.

Nature 2001;412(6847):641-647; Comment in: Nature 2001;412(6847):601-602

 

Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD.

Beta-amyloid activates the mitogen-activated protein kinase cascade via hippoca-mpal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J Neurosci 2001;21(12):4125-4133

 

Dobrucki LW, Kalinowski L, Uracz W, Malinski T.The protective role of nitric oxide in the brain ischemia. J Physiol Pharm 2000;51(4 Pt 1):695-703

 

Dringenberg HC.

Alzheimer's disease: more than a 'cholinergic disorder' - evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia.

Behav Brain Res 2000;115(2):235-249

 



©2015- 2019 stydopedia.ru Все материалы защищены законодательством РФ.